|
Volumn 7, Issue 2, 2002, Pages 149-154
|
A collaborative screening program for the discovery of inhibitors of HCV NS2/3 cis-cleaving protease activity
a a b b b b b b a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIVIRUS AGENT;
BETA LACTAMASE;
HYBRID PROTEIN;
NONSTRUCTURAL PROTEIN 3;
PROTEIN NS2;
PROTEINASE;
UBIQUITIN;
UNCLASSIFIED DRUG;
ARTICLE;
CELL ASSAY;
CONTROLLED STUDY;
DRUG SCREENING;
ENZYME ACTIVITY;
ENZYME DEGRADATION;
GENE INSERTION;
HEPATITIS C VIRUS;
HUMAN;
HUMAN CELL;
MUTANT;
PRIORITY JOURNAL;
PROTEIN DOMAIN;
PROTEIN STABILITY;
REPORTER GENE;
AUTOMATION;
CYCLOHEXIMIDE;
CYSTEINE ENDOPEPTIDASES;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG EVALUATION, PRECLINICAL;
GENES, REPORTER;
HEPACIVIRUS;
HUMANS;
JURKAT CELLS;
MODELS, GENETIC;
MUTATION;
PLASMIDS;
PROTEASE INHIBITORS;
PROTEIN STRUCTURE, TERTIARY;
PROTEIN SYNTHESIS INHIBITORS;
RECOMBINANT FUSION PROTEINS;
HEPATITIS C VIRUS;
|
EID: 0036256391
PISSN: 10870571
EISSN: None
Source Type: Journal
DOI: 10.1089/10870570252906611 Document Type: Article |
Times cited : (26)
|
References (18)
|